Literature DB >> 21968331

The role of bone marrow-derived adult stem cells in a transgenic mouse model of allergic asthma.

Hai-Feng Ou-Yang1, Xin-Peng Han, Feng Zhao, Xin-Yu Ti, Chang-Gui Wu.   

Abstract

BACKGROUND: Asthmatic airway remodeling is an abnormal injury/repair process of the small airways caused by chronic inflammation in which the quantities of multiple cells increase dramatically. However, the origin of these proliferative cells is still undetermined.
OBJECTIVE: The aim of this study was to examine whether bone marrow (BM)-derived adult stem cells are responsible for the proliferative cells in asthmatic airway remodeling.
METHODS: Adult mice were durably engrafted with BM isolated from green fluorescent protein (GFP) transgenic mice. Using GFP BM chimera mice, an ovalbumin (OVA)-induced chronic asthma mouse model was established. The distribution of BM-derived GFP+ cells in the lungs of chronic asthma mice was detected by fluorescence microscopy. The phenotype of BM-derived GFP+ cells in the lung tissues of chronic asthma mice was analyzed by flow cytometry.
RESULTS: BM chimera mice were successfully generated, with no detectable radioactive inflammation observed. Using BM chimera mice, we established a mouse model of chronic asthma characterized by a significant increase in the thickness of the airway subepithelial basement membrane and smooth muscle layers. OVA treatment caused many GFP+ cells to appear at sites of small airway inflammation. The extravascular localization of some GFP+ cells and their morphology were not consistent with leukocytes. Flow cytometric analysis of lung cells revealed a significant increase in type I collagen (Col I)+GFP+ cells and α-smooth muscle actin (α-SMA)+GFP+ cells in OVA-treated GFP BM chimera mice.
CONCLUSIONS: Considerable numbers of Col I- and α-SMA-producing cells originated from BM in the lung tissues of mice with OVA-induced chronic asthma.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21968331     DOI: 10.1159/000330013

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma.

Authors:  J E Trzil; I Masseau; T L Webb; C-H Chang; J R Dodam; L A Cohn; H Liu; J M Quimby; S W Dow; C R Reinero
Journal:  Clin Exp Allergy       Date:  2014-12       Impact factor: 5.018

2.  Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma.

Authors:  L Mariñas-Pardo; I Mirones; O Amor-Carro; R Fraga-Iriso; B Lema-Costa; I Cubillo; M Á Rodríguez Milla; J García-Castro; D Ramos-Barbón
Journal:  Allergy       Date:  2014-04-21       Impact factor: 13.146

Review 3.  Hematopoietic stem and progenitor cells in inflammation and allergy.

Authors:  Kimberly D Fischer; Devendra K Agrawal
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.